The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQFI.L Regulatory News (QFI)

  • There is currently no data for QFI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update re Research & Development Programmes

19 Nov 2015 07:00

RNS Number : 2163G
Quadrise Fuels International PLC
19 November 2015
 

19 November 2015

 

Quadrise Fuels International plc

("QFI", "Quadrise" or the "Company")

 

Research & Development Programmes

 

 

Quadrise, the emerging supplier of MSAR, a low cost alternative to heavy fuel oil in the shipping, oil refining and power generation markets, is pleased to provide the following update on its Research & Development programmes.

 

A Collaboration Agreement was executed with the University of Surrey in Guildford (the "University") on 18 November 2015 (the "Agreement") which provides for the shared use of the University's Centre for Petroleum and Surface Chemistry ("CPSC"), an advanced research facility under the supervision of Professor Spencer Taylor within the Department of Chemistry. The consideration payable by Quadrise to the University for the first twelve months under the Agreement, which is renewable annually, is £78,000. As a result, the Company is relocating its primary emulsion fuels research base from Sweden to the UK.

 

In a related development, the existing Quadrise Research Facility ("QRF") in Essex is being expanded to meet anticipated business support requirements and to develop new MSAR formulations in collaboration with the University.

 

The programme at the University will be directed by Professor Taylor, a world class expert on surfactant and emulsion technology with over 20 years' experience in the petroleum industry with BP, undertaking applied research to underpin intellectual property, as well as upstream and downstream businesses. The CPSC has first class facilities and is ideally equipped with additional hardware and expertise to meet QFI's primary and applied research needs.

 

The intellectual property developed from applied research projects under the Agreement will be exclusively owned by Quadrise, whilst any fundamental research/intellectual property developed under the Agreement will be the property of the University, with Quadrise granted a non-exclusive, royalty free licence - with the option of exclusive rights based on a negotiated settlement. Quadrise will have exclusive rights on intellectual property created from jointly conducted research.

 

The overall research programme will be coordinated with the QRF and tightly aligned with future business needs and imperatives to extend and strengthen the Company's existing competitive advantage.

 

In view of these developments, the primary research programme previously coordinated by Dr Simon Craige in Sweden has been transferred to the UK to facilitate cost effective control and coordination. Dr Craige wished to remain domiciled in Scandinavia for personal reasons and left the Company's employment on 31 October 2015, following an amicable contractual separation.

 

Commenting on these developments, Ian Williams, Executive Chairman of QFI, said:

 

"The agreement with the University of Surrey, together with the relocation of primary research and the extension of QRF, results in the consolidation, expansion and strengthening of all our R&D activities to better serve the anticipated future needs of the Company. We are delighted to be working with Professor Taylor and his team, and to have established the framework for a long term relationship with the University."

 

Professor Dulcie Mulholland, Head of the Department of Chemistry, said:

 

"The University of Surrey and the Department of Chemistry are delighted to establish a relationship with Quadrise. Professor Taylor of our Centre for Petroleum and Surface Chemistry is a leading researcher in this field. We look forward to a long, productive relationship with the company"

 

For further information, please refer to the Company's website at www.quadrisefuels.com or contact:

 

Quadrise Fuels International Plc

Ian Williams, Executive Chairman

+44 (0)20 7031 7321

Hemant Thanawala, Finance Director

Jason Miles, Chief Operating Officer

 

Nominated Adviser

Smith & Williamson Corporate Finance Limited

Dr Azhic Basirov

+44 (0)20 7131 4000

Ben Jeynes

Broker

Peel Hunt LLP

Richard Crichton

+44 (0)20 7418 8900

Ross Allister 

Alastair Rae

 

Public & Investor Relations

Bell Pottinger

Rollo Crichton-Stuart

+44 (0)20 7861 3232

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFFLFWAFISEEF
Date   Source Headline
2nd Feb 20217:00 amRNSUpdate re Morocco and Greenfield Energy Projects
1st Feb 20217:00 amRNSUpdate re bioMSAR Testing at Aquafuel Research Ltd
27th Jan 20217:00 amRNSIssue of Equity
21st Jan 20217:00 amRNSJoint Development Agreement - MSC Shipmanagement
6th Jan 20217:00 amRNSIssue of Equity
4th Jan 20217:00 amRNSChange of Registered Office
18th Dec 202011:46 amRNSUpdate re Greenfield MSAR Trial
18th Dec 20207:00 amRNSbioMSAR Testing Update & Collaboration Agreement
15th Dec 20207:00 amRNSLaunch of bioMSAR
3rd Dec 20207:00 amRNSPublication of Americas White Paper
27th Nov 202012:13 pmRNSResult of AGM
27th Nov 20207:00 amRNSAGM Statement
24th Nov 20208:00 amEQSQuadrise Fuels International (QFI): The clean solution to a global problem
2nd Nov 20205:23 pmRNSPosting of Annual Report and Notice of AGM
26th Oct 20207:00 amRNSMorocco Update
5th Oct 20207:00 amRNSFinal Results, Investor Presentation & AGM Notice
7th Sep 20205:56 pmRNSIssue of Equity
7th Sep 20207:00 amRNSNotice of Results, Update and Investor Event
24th Aug 20207:00 amRNSIssue of Share Options
20th Aug 20207:00 amRNSIssue of Equity
18th Aug 20207:22 amRNSGreenfield MSAR Commercial Trial Agreement
17th Aug 20207:00 amRNSPublication of White Paper
17th Jul 20203:59 pmRNSInvestor Presentation
30th Jun 20209:18 amRNSHolding(s) in Company
24th Jun 20204:41 pmRNSSecond Price Monitoring Extn
24th Jun 20204:37 pmRNSPrice Monitoring Extension
23rd Jun 20207:00 amRNSIssue of Equity
18th Jun 20207:00 amRNSStatement re MSAR Licensing and Upstream Trial
17th Jun 20201:47 pmRNSStatement re MSAR Licensing
2nd Jun 20207:00 amRNSInvestor Presentation
1st May 20207:00 amRNSFurther Statement re Covid-19 and Update
16th Apr 20202:21 pmRNSIssue of Equity
15th Apr 20207:00 amRNSDirectorate Change
30th Mar 20204:13 pmRNSNew Website
30th Mar 202011:02 amRNSHalf-year Report - Replacement
30th Mar 20207:00 amRNSHalf-year Report
24th Mar 202010:13 amRNSIssue of Equity
16th Mar 20207:00 amRNSStatement re Covid-19 and Morocco Pilot Trial
5th Mar 20209:10 amRNSUpdate on Morocco Pilot Trial
17th Feb 20207:00 amRNSNotice of Interim Results and Business Update
30th Jan 20207:00 amRNSAppointment of New Auditors
15th Jan 20207:00 amRNSDirectorate Changes
16th Dec 20198:38 amRNSDirectorate Change
29th Nov 20194:42 pmRNSResult of AGM
29th Nov 20197:05 amRNSIssue of Warrants
29th Nov 20197:00 amRNSAGM Update
29th Nov 20197:00 amRNSMaterial Transfer & Cooperation Agreement
6th Nov 20195:03 pmRNSPosting of Annual Report and Notice of AGM
10th Oct 20195:42 pmRNSHolding(s) in Company
8th Oct 20197:00 amRNSNew three-year Exclusive Agreement with Nouryon

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.